Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Ginekologia Polska
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2023

open access

Vol 88, No 8 (2017)
Research paper
Published online: 2017-08-31
View PDF Download PDF file
Get Citation

The effects of tumor necrosis factor-α (TNF-α) and IL-1 receptor antagonist (IL-1Ra) polymorphisms on recurrent abortion in Azari women

Seyyed Ali Rahmani1, Zeynab Paknejad2, Masoumeh Mohammadkhanlou1
DOI: 10.5603/GP.a2017.0078
·
Ginekol Pol 2017;88(8):421-427.
Affiliations
  1. Department of Molecular biology, Ahar Branch, Islamic Azad University, Ahar, Iran, Iran, Islamic Republic Of
  2. Department of Molecular biology, Ahar Branch, Islamic Azad University, Ahar, Iran

open access

Vol 88, No 8 (2017)
ORIGINAL PAPERS Gynecology
Published online: 2017-08-31

Abstract

Objectives: Recurrent pregnancy loss (RPL) is a heterogeneous condition consisting of three or more consecutive abor­tions before the 20 weeks of gestation. The tumor necrosis factor alpha (TNF-α) gene plays a crucial role in immunology and inflammation responses. Interleukin 1 receptor antagonist (IL-1RN) is an important anti-inflammatory molecule which plays important roles in pregnancy. The aim of this study was to investigate effects of TNF-α and IL-1Ra polymorphisms on RPL in Azari women.

Material and methods: The study participants consisted of 100 women with RPL from Iranian Azeri Turkish origin. The control group comprised 100 age and ethnically matched healthy women in the reproductive age. Genomic DNA was extracted from the whole blood and genotype determinations were performed using PCR amplification followed by restric­tion fragment length polymorphism (RFLP) analysis.

Results: No significant association was indicated between IL-1Ra and RPL among Iranian Azeri Turkish women. Unlike the homozygous state, significantly higher frequency of -857 C/T variant was seen in RPL patients than control subjects. Sig­nificantly lower frequency of wild type genotype was observed in RPL patients than of controls. Any association was found between the other TNF-α polymorphisms and RPL.

Conclusions: TNF-α -857 C/C variant might represent protective effect against RPL and the -857 C/T variant might be a ge­netic risk factor for the occurrence of RPL. Invariant differences in the prevalence of -511 C/T and -31 C/T polymorphisms and IL-1RN VNTR between RPL patients.

Abstract

Objectives: Recurrent pregnancy loss (RPL) is a heterogeneous condition consisting of three or more consecutive abor­tions before the 20 weeks of gestation. The tumor necrosis factor alpha (TNF-α) gene plays a crucial role in immunology and inflammation responses. Interleukin 1 receptor antagonist (IL-1RN) is an important anti-inflammatory molecule which plays important roles in pregnancy. The aim of this study was to investigate effects of TNF-α and IL-1Ra polymorphisms on RPL in Azari women.

Material and methods: The study participants consisted of 100 women with RPL from Iranian Azeri Turkish origin. The control group comprised 100 age and ethnically matched healthy women in the reproductive age. Genomic DNA was extracted from the whole blood and genotype determinations were performed using PCR amplification followed by restric­tion fragment length polymorphism (RFLP) analysis.

Results: No significant association was indicated between IL-1Ra and RPL among Iranian Azeri Turkish women. Unlike the homozygous state, significantly higher frequency of -857 C/T variant was seen in RPL patients than control subjects. Sig­nificantly lower frequency of wild type genotype was observed in RPL patients than of controls. Any association was found between the other TNF-α polymorphisms and RPL.

Conclusions: TNF-α -857 C/C variant might represent protective effect against RPL and the -857 C/T variant might be a ge­netic risk factor for the occurrence of RPL. Invariant differences in the prevalence of -511 C/T and -31 C/T polymorphisms and IL-1RN VNTR between RPL patients.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

TNF-α, IL-1RN, polymorphism, recurrent pregnancy loss

About this article
Title

The effects of tumor necrosis factor-α (TNF-α) and IL-1 receptor antagonist (IL-1Ra) polymorphisms on recurrent abortion in Azari women

Journal

Ginekologia Polska

Issue

Vol 88, No 8 (2017)

Article type

Research paper

Pages

421-427

Published online

2017-08-31

Page views

777

Article views/downloads

666

DOI

10.5603/GP.a2017.0078

Bibliographic record

Ginekol Pol 2017;88(8):421-427.

Keywords

TNF-α
IL-1RN
polymorphism
recurrent pregnancy loss

Authors

Seyyed Ali Rahmani
Zeynab Paknejad
Masoumeh Mohammadkhanlou

References (34)
  1. Ramírez YL, Vivenes M, Miller A, et al. Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage. Clinica Chimica Acta. 2006; 374(1-2): 69–74.
    CrossRef
  2. Omwandho CA, Tinneberg HR, Tumbo-Oeri AG, et al. Recurrent pregnancy losses and the role of immunotherapy. Arch Gynecol Obstet. 2000; 264(1): 3–12.
    CrossRefPubMed
  3. Calderwood CJ. Thromboembolism and thrombophilia in pregnancy. Current Obstetrics & Gynaecology. 2006; 16(6): 321–6.
  4. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2006(2): CD000112.
    CrossRefPubMed
  5. Yu XW, Li Xu, Ren YH, et al. Tumour necrosis factor-alpha receptor 1 polymorphisms and serum soluble TNFR1 in early spontaneous miscarriage. Cell Biol Int. 2007; 31(11): 1396–1399.
    CrossRefPubMed
  6. Hefler LA, Tempfer CB, Bashford MT, et al. A polymorphism of the interleukin-1beta gene and idiopathic recurrent miscarriage. Fertil Steril. 2001; 76(2): 377–379.
    CrossRefPubMed
  7. Baxter N, Sumiya M, Cheng S, et al. Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes. Clin Exp Immunol. 2001; 126(3): 529–534.
    CrossRefPubMed
  8. Gupta R, Prakash S, Parveen F, et al. Association of CTLA-4 and TNF-α polymorphism with recurrent miscarriage among North Indian women. Cytokine. 2012; 60(2): 456–462.
    CrossRefPubMed
  9. Brogin Moreli J, Cirino Ruocco AM, Vernini JM, et al. Interleukin 10 and tumor necrosis factor-alpha in pregnancy: aspects of interest in clinical obstetrics. ISRN Obstet Gynecol. 2012; 2012: 230742.
    CrossRefPubMed
  10. Rossi M, Sharkey AM, Viganò P, et al. Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. Reproduction. 2005; 130(5): 721–729.
    CrossRefPubMed
  11. Glueck CJ, Wang P, Bornovali S, et al. Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss. Metabolism. 2003; 52(12): 1627–1632.
    CrossRefPubMed
  12. Costeas PA, Koumouli A, Giantsiou-Kyriakou A, et al. Th2/Th3 cytokine genotypes are associated with pregnancy loss. Hum Immunol. 2004; 65(2): 135–141.
    CrossRefPubMed
  13. Pietrowski D, Bettendorf H, Keck C, et al. Lack of association of TNFalpha gene polymorphisms and recurrent pregnancy loss in Caucasian women. J Reprod Immunol. 2004; 61(1): 51–58.
    CrossRefPubMed
  14. Zhou L, Cai J, Liu G, et al. Associations between interleukin-1 gene polymorphisms and coronary heart disease risk: a meta-analysis. PLoS One. 2012; 7(9): e45641.
    CrossRefPubMed
  15. Levrant S, Coulam C, Jeyendran R. ORIGINAL ARTICLE: Interleukin 1 Receptor Antagonist Gene Polymorphisms Are Not Risk Factors for Recurrent Pregnancy Loss: Evaluation of Couples. American Journal of Reproductive Immunology. 2008; 60(3): 224–228.
    CrossRef
  16. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis. 2002; 34(2): 204–209.
    CrossRefPubMed
  17. Linjawi S, Li TC, Laird S, et al. Interleukin-1 receptor antagonist and interleukin-1 beta polymorphisms in women with recurrent miscarriage. Fertil Steril. 2005; 83(5): 1549–1552.
    CrossRefPubMed
  18. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009; 27: 519–550.
    CrossRefPubMed
  19. Wu ZQ, Sun L, Sun YH, et al. Interleukin 1 beta -511 C/T gene polymorphism and susceptibility to febrile seizures: a meta-analysis. Mol Biol Rep. 2012; 39(5): 5401–5407.
    CrossRefPubMed
  20. Jassem RM, Shani WS, Loisel DA, et al. HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq. Hum Immunol. 2012; 73(8): 811–817.
    CrossRefPubMed
  21. Moura E, Mattar R, de Souza E, et al. Inflammatory cytokine gene polymorphisms and spontaneous preterm birth. J Reprod Immunol. 2009; 80(1-2): 115–121.
    CrossRefPubMed
  22. Zhang B, Liu T, Wang Z. Association of tumor necrosis factor-α gene promoter polymorphisms (-308G/A, -238G/A) with recurrent spontaneous abortion: a meta-analysis. Hum Immunol. 2012; 73(5): 574–579.
    CrossRefPubMed
  23. Kamali-Sarvestani E, Zolghadri J, Gharesi-Fard B, et al. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women. J Reprod Immunol. 2005; 65(2): 171–178.
    CrossRefPubMed
  24. Finan RR, Al-Irhayim Z, Mustafa FE, et al. Tumor necrosis factor-alpha polymorphisms in women with idiopathic recurrent miscarriage. J Reprod Immunol. 2010; 84(2): 186–192.
    CrossRefPubMed
  25. Babbage SJ, Arkwright PD, Vince GS, et al. Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss. J Reprod Immunol. 2001; 51(1): 21–27.
    PubMed
  26. Traina E, Daher S, Moron AF, et al. Polymorphisms in VEGF, progesterone receptor and IL-1 receptor genes in women with recurrent spontaneous abortion. J Reprod Immunol. 2011; 88(1): 53–57.
    CrossRefPubMed
  27. Unfried G, Tempfer C, Schneeberger C, et al. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril. 2001; 75(4): 683–687.
    PubMed
  28. Karhukorpi J, Laitinen T, Kivelä H, et al. IL-1 receptor antagonist gene polymorphism in recurrent spontaneous abortion. J Reprod Immunol. 2003; 58(1): 61–67.
    CrossRefPubMed
  29. Dai MZ, Pan YQ, Xu DP, et al. IL-1 receptor antagonist gene polymorphism in idiopathic recurrent spontaneous abortion in a Chinese Han population. Int J Immunogenet. 2010; 37(5): 393–396.
    CrossRefPubMed
  30. Vargas-Alarcon G, Ramírez-Bello J, Juárez-Cedillo T, et al. Distribution of the IL-1RN, IL-6, IL-10, INF-γ, and TNF-α Gene Polymorphisms in the Mexican Population. Genet Test Mol Biomarkers. 2012; 16(10): 1246–1253.
    CrossRefPubMed
  31. Agrawal S, Parveen F, Faridi RM, et al. Interleukin-1 gene cluster variants and recurrent pregnancy loss among North Indian women: retrospective study and meta-analysis. Reprod Biomed Online. 2012; 24(3): 342–351.
    CrossRefPubMed
  32. Jaaskelainen E, Keski-Nisula L, Toivonen S, et al. Polymorphism of the interleukin 1 receptor antagonist (IL1Ra) gene and placental abruption. J Reprod Immunol. 2008; 79(1): 58–62.
    CrossRefPubMed
  33. Perni SC, Vardhana S, Tuttle SL, et al. Fetal interleukin-1 receptor antagonist gene polymorphism, intra-amniotic interleukin-1beta levels, and history of spontaneous abortion. Am J Obstet Gynecol. 2004; 191(4): 1318–1323.
    CrossRefPubMed
  34. Barton PT, Gerber S, Skupski DW, et al. Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, and vaginal ureaplasma urealyticum colonization in pregnant women. Infect Immun. 2003; 71(1): 271–274.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl